Mr Ma Bin, Consultant at the Health Emergency Response Office, China’s National Health Commission, read the statement for China at the session

China told the World Health Assembly on Wednesday it will continue to support developing countries’ access to affordable COVID-19 vaccines – but it stopped short of any commitment to supplying its recently-approved Sinopharm vaccine to the WHO co-sponsored Global COVAX vaccine facility. 

WHO officials had said they hoped China would join the COVAX facility, following WHO’s decision to grant the Chinese Sinopharm vaccine an Emergency Use Listing.  COVAX has been badly strapped for doses to send to over 100 low- and middle-income countries after its major supplier, the Serum Institute of India, announced it would have to redirect all of its vaccines to domestic needs following India’s huge COVID surge.  

But China’s WHA delegate said that the country had honored its commitment to provide vaccines as a global public good by providing bilateral vaccine assistance to more than 80 countries, along with exports to 43 more nations – for a total of 300 million vaccine doses. 

“China believes that promoting equitable distribution of and access to COVID-19 vaccines worldwide is crucial to the current pandemic prevention and control,” the delegate said. On the private market, the Sinopharm vaccine is the most expensive in the world – outstripping the cost of the highest-performing mRNA vaccines produced by Pfizer and Moderna.  

 

The Chinese representative also avoided taking a clear position on the proposed Pandemic Treaty. A draft agreement on taking at least the first steps towards a treaty was reached earlier this week among WHA delegates. The proposal – by 26 entities including the European Union, USA, UK and key countries from each WHO region – appeared to be gathering more momentum from other countries as well. 

However, China supports “the concept of building a One Health Surveillance System as well as a whole-of-government and whole-of-society response approach,” the Chinese delegate, Mr Ma Bin, stated. 

In a wide-ranging discussion at the Assembly’s morning sessions, most countries’s statements also stressed the pandemic’s damage to their societies and economies. 

“The emergence of new variants of the virus has overwhelmed the already overburdened health system,” said Ethiopia’s delegate, saying the pandemic had also resented unprecedented social challenges and put enormous strains on economies. 

Strategies to engage communities and communicate effectively with the public are pillars of the Ehiopian response aimed to reduce disease transmission, she said. The COVAX Initiative has meanwhile supported the vaccination of 1.7 million Ethiopian’s at high risk, she added. 

“However, due to the current global situation, our vaccination campaign is seriously challenged, severely hampering our response and management of the spread of COVID-19. This reality is being experienced by many developing countries,” she said. 

Her comments sidestepped any reference to the pandemic or wider health issues faced by Ethiopians in the country’s war-ravaged Tigray region, where UN officials have warned that famine now looms.  

vaccine
Hiwot Solomon, Director, Disease Prevention and Control, Ethiopia’s Ministry of Health: “The emergence of new variants of the virus has overwhelmed the already overburdened health system.”

Sudan’s representative, meanwhile, said that while the pandemic has shaken all health systems, it has widened health service delivery inequities particularly in Low and/or Middle Income Countries (LMICs).

“While Sudan is committed to playing its role in the global efforts for control and prevention of public health emergencies of international concern, challenges remain,” Sudan’s representative said. “This is observed in the difficulties to regularly evaluate legislation, regulations, and policies to facilitate full implementation as well as capacity for infection prevention and control.”

Sudan called for WHO technical support to establish public health laboratories in difficult spaces and to support LMICs with consumable supplies. Sudan said its particular needs include food safety surveillance systems and a poison control center.

COVID – One Among Many Outbreaks Africa Faces 

Dr Matshidiso Moeti, WHO Regional Director for Africa.

WHO Regional Office Director for Africa Dr Matshidiso Moeti described COVID-19 as just one among a number of outbreaks African countries face. She noted the region has endured humanitarian crises as well as outbreaks of Ebola, measles, yellow fever and other diseases.

Still, she said, African governments “have pushed to sustain hard-won health gains and to minimize the pandemic’s impact, and are taking actions to prevent and treat other diseases.”

The pandemic highlights the need to invest in preparedness and the importance of equity in order to protect the vulnerable, Moeti said. “Much needs to be done immediately and in significant quantities to make the difference.”

‘Last Pandemic’ Report Approved

The WHA morning session also formally accepted the report of the Independent Panel for Pandemic Preparedness and Response. This panel was created to provide evidence and historical context to ensure that countries and global institutions, specifically the WHO, will be able to address future pandemic threats.

See also: Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patch Country Response 

Former Liberian President Ellen Johnson Sirleaf, who co-chaired the panel, repeated to the Assembly once more her mantra that actions need to be taken now – so that COVID-19 may be the last pandemic of its kind.

Ellen Johnson Sirleaf: “We identified shortcomings at all stages of the response at both the national and international levels.”

“We identified shortcomings at all stages of the response at both the national and international levels. We also identified successes, and we recognize the hard work and sacrifices made – especially by health workers across the world,” Sirleaf said.

The panel’s goal wasn’t to apportion blame, she said, but to identify the pandemic’s lessons “so that the world can move forward to end the current pandemic and make it the last”.

Former Prime Minister Helen Clark of New Zealand, the Independent Panel’s other co-chair, said that fully acting on these findings can address the current pandemic as well as prevent future outbreaks from becoming pandemics.

‘Two-tiered World’ of Vaccinated and Unvaccinated

Helen Clark, co-chair of the WHO’s Independent Panel for Pandemic Preparedness and Response (IPPR), and former Prime Minister of New Zealand.

As virus deaths continue in the thousands daily, she said, vaccines that provide hope also show development of a two-tier world of the vaccinated and unvaccinated. 

“Immediate action therefore is needed on vaccines,” Clark said. The panel has recommended that high income countries share their existing vaccine doses on a much more massive scale – to free up at least 1 billion doses by September for lower-income member states.  

“At the same time, we urge removing the barriers to manufacturing scale-up by sharing intellectual property and transferring knowledge and technology, and by fully funding the Access to COVID-19 Tools Accelerator (ACT-A),” Clark said. 

She was referring to the WHO co-sponsored initiative that includes COVAX as well as funding for medicines rollout and strengthening health systems. It remains US$ 18.5 billion short of funds needed for 2021, according to senior WHO adviser Bruce Aylward, speaking at the WHA Tuesday. 

Said Clark: “The return on investment would be enormous – both for people’s health and for economies.”

Image Credits: Paul Adepoju , Paul Adepoju.

World Health Assembly side event – COVID-19 and Cross-Border Health Measures, left to right – Apakrishnanarna Ananth, Lisa Forman, Karen Grepin, Catherine Worsnop, Roonjin Habibi, Diego Silva, Barbara von Tigerstrom, James Wiltshire

Controlling a disease outbreak requires cooperation both behind borders and between countries, experts said at a Wednesday event co-organised by the Geneva Graduate Institute’s Global Health Centre.  And one key, neglected area of international cooperation has been travel restrictions, where countries worldwide have created a cacophony of different measures to control COVID.  

“Travel measures are potentially necessary, but they’re not sufficient to control an outbreak. It’s not sufficient to just have strong travel measures in place,” said Karen Grepin, University of Hong Kong associate professor, during the World Health Assembly side event. “We also need a strong national response, a public health response to the pandemic. It can’t just be one or the other.” 

Panelists discussed the impacts of cross-border measures implemented in response to COVID-19. They also considered lessons learned regarding the strengths and weaknesses of the existing International Health Regulations (IHR), which govern country responses, as well as the broader global health ecosystem. 

Travel Measures Must Be Implemented at a Granular Level

travel
Travel measures must take into account local capacity, economic and social circumstance, and legal obligations of countries

These measures need implementation at a granular level, taking into account the “incredible diversity of local capacity, economic and social circumstances, and other legal obligations among member states,” said Barbara von Tigerstrom, Professor at the University of Saskatchewan.

She said experts are making efforts to adapt to a single uniform set of recommendations “when member states are so varied, and especially when things are moving quickly and we need to make quick decisions.” 

Regarding the IHR, von Tigerstrom suggested that evaluating a centralized recommendation or a single set of regulations is not necessary to evaluate what is legitimate or lawful: “If we’re going to use travel restrictions and have them be useful, [then] the more quickly the better.”

Grepin said travel measures also should be rethought in terms of effectiveness: “In the case of COVID, I can say without a doubt that travel measures have been effective in various contexts.” 

Karen Grepin, University of Hong Kong

These measures have been a critical component of national infectious disease response,  Grepin said, and many countries have effective border measures in place they are reluctant to discontinue. 

However, Grepin pointed out, “The reality is that we don’t need to respond like we have in this pandemic to all future threats. Context matters an enormous amount. Some places are more likely to benefit from [these measures] than others, so blanket measures that apply to all state parties are likely to be limited in what they can really [do].” 

James Wiltshire, International Air Transport Association assistant director, also called for a context-based approach for travel measure exit strategies: “There’s not a joined-up approach between measures at the border and measures behind the border.”  

Almost every country in the world has travel measures in place, but those measures are highly inconsistent.  And the IHR rules, which have few provisions about travel in the first place, provide even less guidance on how such measures should be relaxed or removed as the  pandemic is beaten back.

Said Wiltshire each country also faces different contexts, not in terms of disease transmission as well as social and economic pressures: This is a “complex pandemic, with many different countries in different states, so almost certainly a phased removal or relaxation of measures is needed. It is not realistic to expect something that’s prescriptive of the IHR to be followed to the letter of the law, given the range of different circumstances that countries have.” 

High-Income Countries Have ‘Moral Obligation’ Regarding Travel Regulations

Diego Silva, University of Sydney

University of Sydney health ethics lecturer Diego Silva said, “If we’re truly interested in global health, if we’re truly interested in taking seriously the ‘pan’ part of a pandemic, then we need to think through how we interact with each other.”

Silva discussed reciprocity between countries with different income levels. He said travel restrictions and border closures must be understood not just in the context in which they occurred, but also in relation to broader politics and policies. 

Using Australia as an example, Silva said its government is very hesitant on immigration from certain Asian countries, and that “[this] geopolitical reality shapes [Australia’s] border responses.” He said this idea of “state sovereignty used in a protectionist manner” may be “morally problematic, because of the global nature of the virus.” 

He advised that countries need to work on a regional level, at the very least, when it comes to border closures. High-income countries also have a “moral obligation” to work with LMICs on  international travel issues: “It’s not enough to act again in a unilateral manner.”

Potential Gap in IHR Compliance and Policy Implementation   

Catherine Worsnop, University of Maryland

Looking beyond potential IHR revisions and a potential pandemic treaty, University of Maryland Assistant Professor Catherine Worsnop said it’s critical to understand compliance behavior during an outbreak, as well as the potential drivers of variant spread. 

Worsnop found a potential gap between legally compliant behavior and implemented policy when evaluating country compliance in regards to Article 43 of the IHR. 

“Compliance and non-compliance does not capture the full extent of variation and policies that states were actually adopting at the border,” said Worsnop. Implemented policies were not necessarily aligned with the dual purposes of the IHR: to protect health and minimize interference with international traffic.

“We need better clarity on what the IHR are actually aiming to achieve when it comes to cross-border measures, and what counts as compliance really needs to be aligned with that aim going forward,” Worsnop said. 

Roojin Habibi of York University addressed legal considerations in the interpretation of Article 43. The precautionary principle has come up often, notably in reviews conducted by the Independent Panel for Pandemic Preparedness and Response (IPPR), the IHR Review Committee’s report, and the Independent Oversight and Advisory Committee’s report. Yet this “is nowhere written in the text of the IHR,” Habibi said. 

The principle asserts that positive actions, such as a ban on certain activities, may be implemented in order to protect the environment or public health before a risk is scientifically proven. “I would caution us, and would strongly urge us to think carefully about the precautionary principle,” Habibi said. “Doesn’t scientific evidence do the job well enough for us?” 

 

Image Credits: Sanshiro Kubota/Flikr, Global Health Centre/Twitter, Graduate Institute Geneva.

Palestinian medics attend to an young man injured during clashes with Israeli security forces in Jerusalem on 10 May, just before the eruption of violence between Israel and Gaza

A longstanding dispute over a perennial World Health Assembly resolution on the health situation in the Israeli-occupied Palestinian territories claimed a full day of WHA delegates’ attention – as countries on both sides of the bitter conflict battled over a draft decision in a prolonged debate, leading up to a painstaking virtual vote by roll call of all 194 WHO member states.  

Ultimately, Israel lost its bid to defeat the measure – to which it has long objected saying that it singles out the Palestinian issue at the WHA above any other health and humanitarian conflict today. 

A total of 83 WHO member states voted yes, 14 voted no and 39 abstained from the final, approved resolution on the “Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan”. 

The resolution, its 27 co-sponsors led by Algeria, and including South Africa, Andorra and Indonesia and Venezuela alongside nearly two dozen other Arab and North African states, was backed by a detailed report focusing on shortcomings and barriers to the access of health services in Hamas-controlled Gaza and the West Bank, occupied by Israel. 

WHO Regional Director for EMRO Ahmed Al Muntari

The report covers a wide range of longstanding issues faced by Palestinians such as: the lack of access to specialist hospitals in Israeli-controlled Jerusalem; Israeli limitations on the movement of Palestinian emergency services; lack of Palestinian access to COVID vaccines, and an overall lower quality of health services.  The net result of those factors, compounded by chronic violence, poor housing, inadequate water and sanitation services, also leave Palestiniains with a shorter average life expectancy, pointed out WHO’s Ibrahima Socé Fall and Ahmed Al Mandhari, WHO Regional Director for the Eastern Mediterranean, who presented the report.   

The resolution, anchored upon the report, called mainly for the provision of  more WHO support to the Palestinian health sector, equitable Palestinian access to COVID-19 vaccines, and protection of health and humanitarian responders who have faced even greater challenges during the recent 11-spate of clashes between Israel and the Hamas-controlled Gaza Strip.  

However, Israel and its allies also have begun to object more and more vocally over the past year to the centrality the Palestinian measure receives aimed on the WHA stage – unlike that of any other country, humanitarian crisis or disputed territory.  

This year, in particular, sentiments were running at fever pitch – in light of the recent fierce fighting between Israel and the Hamas-controlled Gaza Strip. Those clashes saw 11 days of fiery exchanges of missiles and air power – leaving at least 243 Gaza Palestinians killed, including more than 100 women and children, according to Hamas  – although Israel disputes those figures saying that among the victims in Gaza were more than 150 Hamas fighters.  In Israel,13 people, including two children, died.  

In contrast, a brewing WHA debate over whether to credential Myanmar’s deposed civilian government of Aung San Suu Kyi, or the new military rulers who seized power in February and have since been accused of violently repressing and arresting protestors en masse, was buried by a WHA credentials committee. The committee, meeting behind closed doors Tuesday, kicked on the politically thorny decision to a latter date and the UN General Assembly.  That motion passed without a word of opposition from the WHA plenary on Wednesday. 

Even the normally contentious issue of Taiwan’s exclusion from the WHA passed with just a few remarks by member states in plenary and other meetings yesterday and today. 

Objections by Israel and Allies to “Standalone Item” Have Amplified 

The debates over the health conditions in occupied Palestinian territories and the Golan Heights have gradually became more and more prolonged over the past couple of years, after Israel began to insist on a roll-call vote over the  WHA resolution accompanying the report on health conditions. 

That constitutes Israeli pushback over the extra  attention the issue receives every year in the WHA forum – as compared to other similar reports on health conditions in humanitarian situations and conflict zones – which are either never discussed, or are confined to a footnote.    

A sustained Israeli diplomatic effort among sympathetic member states has gradually yielded some results – although not enough to overturn the vote.  

As the United Kingdom stated:  “We voted no, because we object to the addition of this standalone agenda item at the World Health Assembly, which as we all know is the only country-specific item proposed at this Assembly – and something which we believe needlessly politicizes the WHO and the WHA at a time when collaborative action between us is so needed.

“We supported the report, and the associated decision be considered alongside other WHO assistive programs. 

“We of course, like so many others who remain deeply concerned by the fragile health situation in the occupied Palestinian, especially in Gaza –  and the recent conflict and damage to health infrastructure has exacerbated the needs of the population at the same time that it faces the COVID pandemic. 

“However, we are considering that this Assembly does not scrutinize the other difficult health situations around the world in the same way as it scrutinizes the situation in the occupied Palestinian territories.  And this his item remains the only one of its kind. And we fail, we believe in our duty to serve people around the world who have vitally important health needs. If we allow the WHO become politicized in this way.

Palestine & Syria Retort – What is New?

Syrian delegate to the WHA

Retorted the delegate from Palestine, which represents the Palestinian Authority on the West Bank – and has observer status at the WHA: 

“It’s very sad to hear all of these excuses from some of my colleagues, all of those who spoke of the politicization, voted for this same draft a few years ago. Everyone was for this draft resolution. So what is new, that we have just discovered, that makes everyone believe that this is a politicization, no we’re against anything that makes things more political.” 

The Palestinian delegate also suggested that “if the bombing stops, and ief we have at least the opportunity to have eased access to distribute vaccines, then in that case, we wouldn’t even need a resolution” – adding that she hoped next year Palestine would also become a full member of the World Health Assembly. 

“What we are attempting is to establish responsibility, we do not want to harm anyone but this means of going forward is something that we reject. And it is a major hindrance for the health sector of Palestine, and it is not in conformity with the Geneva Conventions, I thank you very much for your kind attention.”

Added Syria, Israel’s allegations that the resolution politicized the work of the WHO, “is a sheer misleading campaign” saying it was a “technical text….  which is presented in the context of the mandate or who it confirms the determination of the international society, to provide protection and health care to the Palestinian people and the Syrians under occupation.”

The bitter dispute, as Syria noted, also extends to the Golan Heights, over which Israel has extended Israeli law – providing Syrian Druse communities living there with access to Israeli health and social security services –  as well as a pathway to citizenship. 

“This relates to Syrian citizens, who are under foreign occupation, and who are being referred to by the Israeli occupying power under misleading terms, to justify its illegal decisions to annex the Syrian Golan.”

Israel meanwhile said that member states who adopted the decision have allowed the Syrians to whitewash their political crimes – and allow the Palestinians to use this forum for their political goals, and adopt a decision that is far removed from reality. 

Meirav Eilon Shahar, Israel’s ambassador to the UN in Geneva

“Let’s stop the politicization of this forum, by deleting this  from the agenda,” said Meirav Eilon Shahar, Israel’s ambassador to the UN in Geneva. “Health can be a bridge to peace. This decision has become a ritual, its time to stop that. It’s time to build back better.” 

Image Credits: www.laprensalatina.com.

Piazza di Spagna. Rome – Scenes from the suppressed WHO Report, An Unprecedented Challenge

EXCLUSIVE: The Geneva Observer has learned that Transparency International and a broad coalition of organizations advocating for a more robust protection mechanism for UN whistleblowers has sent an open letter to the 74th World Health Assembly (WHA) urging WHO Member States to call for an independent review of the disclosures made by former WHO researcher Dr Francesco Zambon in the case of the sudden and highly controversial withdrawal of a report about Italy’s response to the COVID-19 pandemic in May 2020.

Dated Wednesday (May 26), the letter also demands the WHO reform “its whistleblowing mechanisms and ensure the independence of its justice system for future whistleblowers.”

The report, “An Unprecedented Challenge: Italy’s first response to Covid-19,” was published a little over a year ago on WHO’s European Regional website, then withdrawn after a few hours and never republished, even though it had been approved by the organisation’s scientific committee. To this day, WHO maintains that the report was prematurely published and withdrawn because it contained “factual inaccuracies,” an assertion contradicted by documents gathered by Italian prosecutors in Bergamo investigating why Italy’s pandemic plan had not been updated since 2006.

Transparency International Letter Sent to WHA President 

Transparency International’s strongly worded open letter was sent to the President of this year’s WHA, Bhutan’s Health Minister Dasho Dechen Wangmo. In addition to Transparency International, the open letter is supported by the Whistleblowing International Network (WIN), the Government Accountability Project (GAP,) and more than 30 anti-corruption, public health, and whistleblower protection organizations and individuals.

“We are all deeply concerned about the case on public health grounds from two perspectives,” the TI letter states.

“First, we are concerned with what appears to be the deliberate suppression of a scientific report of great public interest value at the time it was published and still valuable for ongoing learning. Second, the alleged retaliation against Dr. Zambon for reporting his concerns about the report’s suppression highlights serious failures of WHO’s whistleblowing policy – an essential element of any institution’s good governance.”

WHO’s Franceso Zambon resigned after he spoke out against the Organization’s censorship of a crucial report on Italy’s botched COVID-19 response

The coalition’s demand comes as civil society has been warning that freedom of expression and the public right to quality information was essential during a pandemic and, as the open letter states, “that those who expose harms, abuses and wrongdoings should be protected.”

Guerra Pressured Zambon to State that Italy’s Pandemic Plan had been Updated 

Documents obtained by The GIO reveal that on May 11, 2021, two days before the report was posted online, Dr. Ranieri Guerra, then WHO Assistant Director General in charge of Special Projects, seconded to the Italian Ministry of Health, pressured Francesco Zambon, the WHO’s Venice-based staff official who coordinated the writing of the report with a team of ten experts, to insert language claiming that Italy’s preparedness plan had last been revised in 2016 when in fact it had not been updated since 2006 – something that Zambon refused to do.

Former WHO Assistant Director General, Ranieri Guerra

Guerra had no formal authority over the publication of the WHO report. Updating Italy’s preparedness plan was, however, supposed to have been his responsibility when serving with the Ministry of Health in Rome prior to being appointed to the WHO by new Director-General Dr. Tedros Adhanom Ghebreyesus in October 2017.

“You must immediately correct the text. (…) Don’t mess with me on this one and please no bullshit.(…) Sorry for the tone” Guerra wrote in his email, which he followed with an irate phone call to Zambon. According to knowledgeable sources who spoke to The Geneva Observer under the condition of anonymity, the relationship between the two men – while appearing cordial in some previous exchanges – had become strained from the moment the decision to write the report was made in March.

Italian Prosecutors Now Investigating Guerra for Alleged “False Testimony”

The exchanges and other documents are, now with the Italian prosecutors who are investigating Guerra for possible “false testimony” regarding his role in Italy’s preparedness planning and the WHO pandemic account.

Those same documents suggest that Dr. Tedros’ envoy to Italy was, from the beginning more preoccupied by his own and WHO’s relationship with the Italian government than by the report itself –  whose main objective was to share Italy’s experience and lessons learned with the world in the hope that other countries could be better prepared:  “Writing such a history is certainly a good idea (…), I am sure it will also please the government,” Guerra wrote to Zambon on March 25.

On April 14, in another email, Guerra told  Zambon that the researcher had  complete latitude to have his team write the report as they see fit. However,  he advised Zambon to “provide the [Italian] Health Minister with a more detailed index” of what the report would contain so the “Minister can give his blessing” to this as well as having the funding for writing the report provided by a foreign country.

Guerra demands a change in the report to say that the pandemic preparedness plan was “updated” in 2016 – the changes were not made.

According to documents and confirmed by the sources contacted by The G|O, Zambon and his team accepted that the Italian government should be informed about the writing of the report as a matter of “institutional courtesy” but that the document itself should not be shared in order to protect and maintain the WHO’s credibility and independence.

Guerra’s  claim insistence that the Italian pandemic plan had been updated was also debunked by a forensic expertise of the metadata of the 2006 plan’s PDF file. That file was  – published by the Italian public-broadcaster RAI in December 2020.

Guerra was trying to cover up what could be called “a dereliction of duty while he was in charge of prevention at the Italian Health Ministry,” a WHO insider told the Geneva Observer. In his defense, Guerra claims that the final responsibility to update the circa 2006 Italian pandemic plan was not in fact his -, a determination that in the end will be made by Italian justice.

Related stories:

·         The Italian Job: Obfuscation and Influence at the WHO

·         Senior WHO official under investigation in Italy denies lying to prosecutors

·         World Health Organization’s Censorship Of Report On Italy’s Pandemic Response Sets Dangerous International Precedent – Critics Say 

·         WHO Playbook For Responses To Media Queries On Suppressed Italian COVID-19 Report – Raises More Questions than Answers

Pressure Followed by Intimidation 

Pressure on Zambon was allegedly followed by intimidation.  According to Zambon, who has since resigned from his position in WHO’s Venice office, to the former WHO researcher, Guerra reportedly told him during a phone call on that same day, May 11, that he would have him fired by WHO DG Dr Tedros if he refused to modify the document.

The exchange prompted Zambon to immediately report the episode to WHO’s Ethics Office and informed it that he was taking a medical leave of absence due to “a threat email I received” from Assistant DG Guerra.

WHO Ethics Office Denies Zambon Whistleblower Protection

Several months later, WHO’s Ethics Office responded that Francesco Zambon could not have been a victim of retaliation as he did not have a reporting line to ADG Guerra: “Therefore, ADG Guerra’s alleged comments, while inappropriate, do not constitute retaliation(…)as defined by WHO policy.” The same email to the former researcher states further that: “…you were advised that as there has been no retaliation against you at this stage,” and that “therefore there is no need for protection.”

Zambon, isolated professionally and boycotted by his colleagues, subsequently resigned. Guerra, meanwhile, has become a special advisor in the Director General’s office – although according to existing WHO staff rules, he would be obliged to return when he turns 68 in June – beyond which even exceptional extensions of staff positions by the director-general are not supposed to be permitted.  WHO, however, did not comment on Guerra’s job status.

Transparency International Condemns WHO’s Decision on Zambon 

Transparency International’s letter strongly condemned WHO’s this decision to deny Zambon protections:

“The WHO’s unresponsiveness to Dr. Zambon’s attempts to raise serious public interest issues, and the lack of a timely resolution of his complaints of retaliatory treatment can only have a chilling effect on other WHO staff, as well as those working for similar international bodies, discouraging them from speaking up when it matters. The case also risks fueling serious distrust in WHO and UN systems” the letter reads. (…)” The whistleblowing policies of the United Nations have been a long-standing cause for concern for international whistleblowing protection and anti-corruption and human rights experts.

Zambon, in response to the TI letter, told The Geneva Observer and Health Policy Watch: “Over the last months I have been seeing from WHO officials the most bizarre statements on this issue.  Either there was a cover-up or else they simply don’t know the full facts.  Now that Transparency International spontaneously got this, I wait for an apology from WHO. Now I feel less alone.”

Asked to comment, a WHO spokesperson said that the Organization was “currently working on a reply to Transparency International”.

The WHO spokesperson acknowledged that in the case of Zambon, a “complaint by him against another WHO staff member was received by WHO in 2020 and is currently under review.

But the spokesperson contended that  Zambon, who resigned effective 31 March, “is not a whistleblower under WHO policy on whistleblowing; professional conflicts between staff members are handled in line with WHO’s regulatory framework and Zambon has availed himself of the options open to staff members in that respect.”

“WHO is cooperating with the Public Prosecutor in Bergamo, following his request for judicial assistance,” the spokesperson added.

UN Special Rapporteur’s Recommended UN Agencies Adopt Stronger Whistleblower Protections 

In 2015, the UN Special Rapporteur on freedom of expression specifically recommended the UN and its agencies” adopt effective policies to enable greater public access to information and to protect whistleblowers.” The open letter also refers to a report by WHO’s External Auditor scheduled to be discussed during WHA74.

“We note with keen interest that our concerns and calls for reform have been echoed in the findings of the Report of the External Auditor, published May 17, 2021, and scheduled for discussion on WHA74 preliminary agenda. The Report found a steep increase in the number of complaints of misconduct and retaliation and confirmed this should be a cause for concern for WHO management. Reported breaches of the WHO’s Codes of Ethics and Conflicts of Interest more than doubled, and complaints of retaliation sharply increased from 7 (in 2019) to 19 (in 2020). The CRE received a further 20 complaints. The Report stated that an ‘untenable’ lack of human resources’…[h]ampers the cause of justice’ and the resulting delays are particularly problematic given the large number of cases later found to be substantiated. (…) WHO should enhance its punitive and preventive measures, and urgently reduce delays in investigation and disciplinary action.”

Philippe Mottaz / @pmottaz – is the founder and editor-in-chief of the Geneva Observer.  Updated with permission from the article first published in The G/O on 26 May, 2021. 

Image Credits: WHO, An Unprecedented Challenge .

Ajoke Sobanjo-ter Meulen, Princess Nothemba (Nono) Simelela, Wiweka Kaszubska, Alwyn Mwinga, Jamie Nishi, Andrew Tuttle, Lisa Goërlitz (from top left to right)

Although gender is increasingly factored into health research, much remains to be done, experts reported at a Tuesday event co-organised by the Geneva Graduate Institute’s Global Health Centre.

But despite growing awareness, health research continues to conceptualize gender in binary terms. Very little research concerns those who identify as LGBTQ+, according to speakers at the event, which was co-sponsored by the Medicines for Malaria Venture, the Global Health Technologies Coalition, Deutsche Stiftung Weltbevölkerung (DSW International), and the International Geneva Global Health Platform. 

Panellists explained how diseases can have vastly different impacts on different genders because of social and economic factors. Women are under-represented in pre-clinical and clinical trial research, leading to limited data on risks and benefits of tested medicines and vaccines. Later impacts of this bias eventually may limit women’s therapeutic options.

Pregnant women are an especially vulnerable category, often left out of clinical trials altogether.  

Involve Communities, Improve Trust

Alwyn Mwinga, CEO, Zambart Project; Zambia DNDi Board Patient Representative said the key to involving more women in research is to improve trust.

Panellists repeatedly stressed the need to work closely with communities while designing solutions, as currently researchers have inadequate consultations with women.

“This element of trust actually underscores the importance of important community research, and this is more impactful,” said Alwyn Mwinga, Zambart Project CEO and Zambia DNDi Board Patient Representative.

She said the take-home message is that pregnant women are willing to participate in research, provided they are given sufficient information to make a considered decision. She added that while more women are included in recent clinical trials, a lot more needs to be done.  

Among the barriers to including more women in clinical trials were onerous paperwork involved in the consent process and cultural issues surrounding consent: if women must refer such decisions to a spouse or parents, this calls into question the process of informed consent. 

Neglected Diseases and Skewed Funding

Bias isn’t limited to gender issues — inequities also mark funding for research into various diseases. Some diseases get more funding than others, and those that concern women the most may be neglected.  

“In 2018 we saw $US 1.7 billion invested across these health issues … and, maybe unsurprisingly, the lion’s share of that — nearly 85% — went to HIV/AIDS,” said Andrew Tuttle, Policy Cures Research research director. Research is lacking about pregnancy-related conditions, and this slows development of drugs and technologies for pregnancy-related conditions.

Poverty-related neglected diseases are another neglected area. “The same disease might have different consequences on different genders or different sexes because of the role of women and girls in society or because of expectations towards different gender roles and so on,” said Lisa Goërlitz, DSW Brussels Office EU Advocacy Unit head.

She said there is almost no data on how these diseases affect LGBTQ+ community members.

Gender dimensions have significant impact on health outcomes depending on stigma and discrimination, as well as different financial and social outcomes.

Ajoke Sobanjo-ter Meulen, lead of Maternal Immunisation, Bill & Melinda Gates Foundation said that maternal immunisation can serve as an example for other health programmes

While stakeholders like manufacturers, policy-makers and communities can make a difference, women have made direct efforts to be included in research.
“Women’s autonomy and agency — I think that played a very important role. The Zika example and Ebola example are very critical here, because in both instances pregnant women demanded to be included in clinical trials, which initially did not happen,” said Ajoke Sobanjo-ter Meulen, maternal immunisation lead at the Bill & Melinda Gates Foundation.

Thanks to these milestones, subsequent outbreaks have seen pregnant women included in earlier stages of research.

The 74th World Health Assembly convenes under the theme: “Ending this pandemic, preventing the next: building together a healthier, safer and fairer world.”

Bold decisions are required to strengthen the World Health Organization and equip it with authority and resources it needs to address glaring shortcomings in pandemic preparedness and response, the 74th World Health Assembly was told on Tuesday.

Recommendations emerging out of a report by the Independent Oversight and Advisory Committee (IOAC) for the WHO Health Emergencies Programme were presented to the Assembly on Tuesday.  While the committee was supposed to focus on the WHO Emergencies response, as such, its criticisms of failings were more focused upon the insufficient lack of global political will to fight the pandemic, a lack of global solidarity and planning.

“Overall, IOAC is satisfied with the achievements made, and impressed by the [WHO] Secretariat as continuous efforts are made to implement the IOAC recommendations,” said IOAC chair Felicity Harvey in her presentation to member states. “And I would also like to recognize that Dr Tedros is committed to implementing our recommendations – and indeed some recommendations issued in this report are already being implemented as we speak. 

Those recommendations include more intensive work with Member States “to improve and clarify risk assessments, corresponding alerts, and empower IHR national focal points to take informed action”. In addition, she said the IOAC report found that WHO should review existing tools for “national and international preparedness,” as well as the use of travel restrictions in the pandemic context.

Other recommendations include strengthening of core WHO technical expertise and revising staffing and related grading processes, including clearer roles and responsibilities for the director-general, regional directors and other senior staff, with respect to emergencies.

However Harvey said the IOAC was also calling upon member states to review whether WHO had the strategic capacity to support country pandemic preparedness and if it had sufficient funding to lead multidimensional and large-scale emergencies like the COVID-19 pandemic.

“The world looks to WHO for guidance, but to serve that purpose WHO must be equipped with the necessary authority and resources to coordinate pandemic prevention and response. “

“IOAC will continue to hold WHO accountable, but Member States and partners must play their part as well, to help the Organization fulfil its role in protecting the health of populations across the world,” Harvey said. “Global health is truly a shared responsibility.”

Regarding the recent allegations of sexual harrassment and exploitation among WHO staff in the Democratic Republic of the Congo, the IOAC said it was concerned about the fact-finding process’s slow progress.

Two media recent reports have detailed allegations by women who said male aid workers responding to the Ebola crisis in the eastern DRC offered them jobs in exchange for sex.  In one report, a woman working as a nurse’s aide in northeastern Congo alleged she was offered a job from a WHO doctor at double her salary in exchange for sex. 

“We urge WHO to immediately implement preventive and response measures in areas that are potentially high-risk for sexual exploitation and abuse. The IOAC recommends that WHO conduct a cross-Organization review of the current tools, structures, processes and coordination mechanisms to prevent, mitigate and manage all potential risks linked to emergency operations for both staff and communities,” Harvey said.

‘WHO Strengthened Its Leadership Position’

IOAC chair Dr Felicity Harvey

Though the report exposes failings in pandemic preparedness and response, Harvey said the commitee found numerous examples of “global solidarity and collaboration, together with remarkable progress in research and development”.

“Despite the challenges faced, the report concludes that WHO has maintained, and indeed strengthened, its leadership position in the global response throughout the pandemic,” she said.

The IOAC also voiced support for WHO Director-General Dr Tedros Ghebreyesus, the public face of WHO efforts since the SARS-CoV-2 virus emerged in the Chinese city of Wuhan in late 2019. It said it was “deeply concerned by the high level of toxicity and incivility on social media against WHO and its personnel”.

“The Committee strongly condemns personal attacks against the Director-General and WHO staff members, and recommends that WHO build capacity to deploy proactive countermeasures against misinformation and social media attacks, and further invests in risk communication as an essential component of epidemic management.”

Reaction to Three Critical Reports

The report is one of three documents critically reviewing the global pandemic response – and the document most focused on WHO’s own emergency performance. The other two reviews were undertaken by the Independent Panel for Pandemic Preparedness and Response (IPPR) and the International Health Regulations Review Committee (IHRC). The Independent Panel report focused broadly on the failures of the global community and member states, although also with reference to WHO’s strengths and shortcomings.  The third report focused on the limitations of the current International Health Regulations, which comprise the legal framework governing emergency response. 

A number of member states welcomed the recommendations by the three reports and called for their immediate implementation.

South Africa said “business as usual can’t be an option anymore.” Meanwhile, the United States said it was ready to work with all WHA member states to translate recommendations into concrete change and tangible improvements.

Canada urged member states to “build coordinated, cohesive and efficient systems to respond to various recommendations to ensure actions don’t unintentionally result in further fragmentation, new structures or a fallout”, while Denmark called for further collaboration to safeguard critical societal functions. 

Mexico voiced its concern over the speed at which decisions are being implemented. Russia was also critical, saying not all conclusions and recommendations made by the commissions were “fully in line with an accurate analysis of the COVID-19 pandemic”.

Portugal, speaking on behalf of the European Union and its member states, urged the WHO to facilitate discussions among experts on all recommendations made by different commissions and report back to member states.

Image Credits: World Health Assembly.

Public health measures, including physical distancing, mask wearing, and hand hygiene, will continue to be necessary as the world is still in the “deepest part of this pandemic,” according to WHO officials.

The number of pandemic-related cases and deaths have rapidly accelerated in the first four months of 2021, said WHO officials on the second day of the 74th World Health Assembly – and despite sharp declines seen in almost every region over the four weeks, the situation remains “fragile.”

The “highly unstable” global epidemiological situation, combined with the slow global vaccine rollout, requires continued enforcement of public health measures worldwide, said Mike Ryan, WHO Executive Director of Health Emergencies. 

As of Tuesday, 167 million cases and 3.47 million deaths have been recorded since the beginning of the pandemic, although these figures are likely under-representative, according to WHO.

Cases have doubled since late December, and 2021 so far has seen a death toll of 1.6 million, compared to 1.82 million in all of last year.

Peaks in cases in all WHO regions were seen in late 2020 and into the first four months of 2021, fueled by increased social mixing, relaxation of public health measures, emergence of more transmissible SARS-CoV2 variants, and inequitable vaccine distribution. 

The rise in cases has burdened health systems, with ICUs operating at capacity and a shortage of beds, oxygen and therapeutics. 

“Recent weeks have shown an overall decline in reported cases, but the global situation remains fragile and volatile, with significant outbreaks in countries across all regions of the world,” said Ryan.

The global number of new weekly COVID-19 cases since the beginning of the pandemic, separated by WHO region.

According to the WHO COVID dashboard, sharp declines were reported in the past two weeks. As of May 17, new cases weekly appeared to have declined to 4.19 million globally – as compared to a peak of 5.69 million at the all-time pandemic peak on April 26.

This past week has seen the number of new cases drop further to roughly one million, according to WHO figures. However, the data may be incomplete as of May 24.

Despite the high numbers of deaths cumulatively – amounting to 3.5 million deaths so far reported to WHO and possibly far more in terms of unreported deaths – overall mortality rates also have declined over time. Ryan attributed that to earlier clinical care, effective use of oxygen and the steroid dexamethasone, and the fact that more health systems have gained experience in treating COVID cases, including during surges.  

The proportion of critically ill COVID-19 patients that died declined from nearly 40% early in the pandemic to approximately 16%.  

Public Health Measures Remain Essential to Curb Transmission

Although countries have learned from a year of experiences with containing the virus, contact tracing, and treating severely ill patients, the world remains “in the deepest part of this pandemic,” Ryan said. 

“Current estimates suggest that over 80% of our communities need to have immunity to stop or interrupt transmission. However, data from serologic studies around the world indicate that no countries have acquired this level of natural immunity. A substantial proportion of the world’s population remains susceptible to infection,” Ryan said. 

While COVID-19 vaccines could close the immunity gap, their distribution continues to be uneven and unfair. Some 83% of the 1.6 billion doses administered globally have been used in high- and upper-middle-income countries, which account for just half the world’s population. 

The difference in the number of doses administered per 100 people between high-income and low-income countries is more than 75-fold.

Now, however, countries that have conducted rapid an intensive vaccination campaigns – such as Israel, the United Kingdom and the United States – are seeing the rollout begin to slow – as all of those wishing to be vaccinated have done so.

Approximately 62.9% of Israel’s population have received at least one dose, but the country’s daily vaccines administered per 100 people dropped from 2.14 in late January to 0.05 in late May. 

Those countries have also seen very sharp declines in cases. However Ryan cautioned against over-optimism about what vaccines could achieve more broadly in light of the slower vaccine rollouts going on elsewhere – and the ongoing dearth of vaccines in many low- and middle-income countries.

As a result, “it is unlikely that many communities will achieve the very high levels of herd immunity required to control transmission anytime soon,” said Ryan. 

Public health measures that are the mainstay in controlling transmission will thus continue to be critically important for months to come. These include physical distancing, mask wearing, hand washing, robust testing, contact tracing, quarantining, and clinical care of cases. 

“We must stay the course while striving to increase vaccination coverage,” Ryan said. “Continuing to suppress viral transmission and dissemination is vital everywhere, regardless of vaccination rates – and is all the more critical given that the SARS-CoV2 virus continues to evolve.”

Dr Mike Ryan, WHO Executive Director of Health Emergencies Programme, at the World Health Assembly on Tuesday.

Currently, four variants of concern and six variants of interest are being monitored and examined for links to heightened transmissibility, more severe disease, and reduced vaccine efficacy. 

Evidence suggests that the available vaccines remain effective against the variants of concern, and that public health measures are able to control the variants’ spread. 

Short-term priorities include implementation of effective public health measures and enhanced national, regional and global surveillance and monitoring. Over the medium term, production and equitable distribution of vaccines, therapeutics and diagnostics need to be scaled up, and health systems’ resilience and capacities should be strengthened.

WHO Pandemic Initiatives Facing Funding Shortage

The Access to COVID-19 Tools (ACT) Accelerator, a global collaboration to speed up the development and distribution of diagnostics, therapeutics and vaccines, faces a US$18.5 billion financing gap. 

The ACT Accelerator is poised to deliver over two billion vaccine doses, 900 million rapid tests, and 100 million treatment courses in the coming year if funding challenges are overcome, said Dr Bruce Aylward, Accelerator lead and senior advisor to the director general. 

The diagnostics, vaccines and therapeutics delivered by the ACT Accelerator over the past year.

The COVAX Facility, one pillar of ACT-A, has shipped 72 million doses to 123 countries; 32 of those countries were only able to start their vaccination campaigns due to COVAX. 

“There’s no question that COVAX works. The challenge is getting the vaccines into the facility through the cooperation and support of countries and companies to be able to address the increasing inequity in distribution,” Aylward said. 

The equity gap extends beyond vaccines to tests and treatments, with high-income countries conducting 125 times more tests per day than low-income countries. 

“If you can’t see the virus, you can’t manage your outbreak, and you can’t understand the gravity of the situation – until it’s too late and you’re faced with catastrophic consequences,” Aylward said. 

Low- and middle-income countries, including India and Brazil most recently, have an oxygen shortage of 3.3 million cylinders per day currently needed to treat COVID-19 patients. 

“Inequities are prolonging the impact and duration of the pandemic,” said Ryan. “Urgent action is required not only to address inequitable access to health care and to vaccines, but to ensure that countries have the capacity to translate vaccines into vaccination, diagnostics into effective surveillance, and therapeutics into treatment.”

Nearly US$14.6 billion has been pledged to ACT-A, but the funding gap will have to be closed to carry out procurement and equitable rollout of critical tools. 

“Without that financing, we are unable to manage the response, roll out the vaccines, ensure we are testing, keep health care workers safe with PPE [personal protective equipment], and treat those with severe disease with oxygen and steroids,” Aylward said. “With financing alone, we cannot access doses because the vast majority are contracted through the end of this year.” 

Dr Bruce Aylward, Senior Advisor to the WHO Director General and lead for the ACT Accelerator.

Integrating and Financing WHO’s Pandemic Plan is Next Step in Closing Equity Gap

Fully funding and integrating WHO’s COVID-19 Strategic Preparedness and Response Plan for 2021, which was launched in February, within ACT-A will be crucial for the delivery of COVID products, stressed Aylward.

The Strategic Preparedness and Response Plan translates the knowledge from the global response to the pandemic in 2020 into strategic actions and guides coordinated measures. The Plan for 2021 is requesting US$1.96 billion to fund WHO’s efforts to end the acute phase of the pandemic. 

“If we want to expand now from the product development work, which has been so successful, to in-country delivery work, there has to be a strong WHO coordinating capacity,” said Aylward.

“We have the tools, [now] we got to have the capacity to support in-country uptake and use,” Aylward added.

The Plan currently has a funding shortfall of over 70%, which leaves “the organization in real and imminent danger of being unable to sustain core functions for urgent priorities,” said Ryan. 

More than 90% of the US$576.1 million received by WHO have been earmarked and just 8% of the funding is flexible. 

“This underfunding and earmarking of funds risks paralyzing WHO’s ability to provide rapid and flexible support to countries and is already having consequences for current operations,” said Ryan.

Some member states supported and joined the call for more flexible funding at a World Health Assembly session on Tuesday.

“We urge the member countries to consider predictable, sustainable and unearmarked financing to enable WHO to deliver on the functions entrusted to it under the International Health Regulations 2005,” said Shanchita Haque, Bangladesh’s delegate.

Shanchita Haque, Deputy Permanent Representative at the Permanent Mission of the People’s Republic of Bangladesh to the United Nations.

“Sweden remains a strong supporter of unearmarked funding to WHO and calls on member states to take responsibility,” said Sweden’s delegate. “We cannot expect WHO to deliver extensively without the means to do so.”

Member States Called Upon to Donate Doses 

The sharing of doses will be a crucial part of WHO Director General Dr Tedros Adhanom Ghebreyesus’ plan to vaccinate a quarter of a billion more people in the next four months, which he laid out in his opening remarks at the World Health Assembly. 

“Today I am calling on Member States to support a massive push to vaccinate at least 10% of the population of every country by September, and a ‘drive to December’ to achieve our goal of vaccinating at least 30% by the end of the year,” said Tedros on Monday.

Some 10 countries have recently announced plans to share over 150 million doses, but more will be needed in May and June to reach the goal by September, Aylward said. 

Image Credits: Flickr: IMF Photo/Joaquin Sarmiento, WHO.

Healthcare workers in Nigeria fight to maintain vaccination services during the COVID-19 pandemic.

 

Key World Health Organization (WHO) member states agreed to postpone a potentially polarising discussion on a ‘pandemic treaty’ until November, according to a World Health Assembly ‘draft decision’ published Tuesday.

The proposal – by 26 entities including the European Union, USA, UK and key countries from each WHO region – specifies that a special WHA session should be “dedicated to considering the benefits of developing a WHO convention, agreement or other international instrument on pandemic preparedness and response”.

This special WHA would establish “an intergovernmental process” to draft and negotiate this instrument, “taking into account the report of the Working Group on Strengthening WHO Preparedness and Response to Health Emergencies”. 

Previously, the US had advocated for a high-level ministerial meeting to consider the possibility of an international instrument or treaty.

Late Tuesday afternoon, Germany delivered a statement on behalf of 59 countries that now support the  special session of the WHA in November to discuss a possible pandemic treaty.

“In our view, a pandemic treaty under the roof of the WHO is the preferred way forward to strengthen the multilateral health architecture,” said Germany in the statement.

Mike Ryan, WHO Health Emergencies Programme Executive Director, appealed Tuesday for “the highest-level political commitment” to address the organisation’s weaknesses in the face of pandemics. 

Dr Mike Ryan, WHO Executive Director of Health Emergencies Programme.

Reciting a lengthy list of epidemics that had ended with unmet promises to fix global responses, Ryan said, “If I had a dollar for every recommendation made in this space, I would have a completely funded programme.”

“My personal view is that we need a political treaty that makes the highest-level commitment to the principles of global health security — and then we can get on with building the blocks on this foundation,” Ryan told a lunchtime briefing on pandemic preparedness.

Since November the European Union has advocated a pandemic treaty similar to the Framework Convention on Tobacco Control, but has faced opposition from the US, Russia and Brazil. (The tobacco convention provides signatories with evidence-based tobacco control strategies that they are obliged to implement, albeit incrementally.)

Russia’s WHA representative told Tuesday’s plenary that there was no need for additional requirements beyond the International Health Regulations, as these are binding global regulations to prevent the spread of disease.

US public utterances have been vague, although an earlier Health Policy Watch report indicated the US was trying to stall discussions by proposing various diplomatic measures such as a high-level ministerial meeting to consider setting up an “international instrument”.

US Health and Human Services Secretary Xavier Becerra

Addressing Tuesday’s plenary, US Health and Human Services Secretary Xavier Becerra called for “urgent action this year to strengthen health security and pandemic preparedness” by “improving global triggers.” 

Measures should include a “sustainable global health security financing mechanism” and developing “surge capacity” for global manufacturing of personal protective equipment, vaccines, therapeutics and diagnostics, said Becerra.

However, comments from various US officials during the Assembly indicate that the country is concerned about the financial responsibilities attached to any legal framework, which might be difficult to get domestic support for.

EU Upbeat About Pandemic Treaty

Meanwhile, the EU delegations to the United Nations in Geneva were positive about the draft decision.

“Ahead of the World Health Assembly, the EU and a group of countries from across all WHO regions built a large coalition to ensure that WHA74 would pave the way for establishing a process for a Framework Convention on Pandemic Preparedness and Response,” according to a statement from the EU delegations.

“The decision to be adopted today by the Assembly will set up a special session of the WHA in November 2021 to focus on this one issue with a view to starting the formal negotiation process immediately thereafter.”

Also Tuesday, Charles Michel, President of the European Council, reiterated the EU’s call for an international treaty to “foster a comprehensive approach to better predict, prevent and respond to pandemics, strengthen global capacity and resilience to ensure fair access to medical solutions, and bolster international alert systems that are sharing … cutting-edge medical research.”

Three Perspectives on WHO Inadequacies

Helen Clark, co-chair of the WHO’s Independent Panel for Pandemic Preparedness and Response (IPPR), and former Prime Minister of New Zealand.

Three key reports – from the Independent Oversight and Advisory Committee (IAOC), the Independent Panel for Pandemic Preparedness and Response (IPPR), and the International Health Regulations Review Committee (IHRC) – have laid bare various WHO failures in the face of COVID-19.

The IPPR presented its report to the WHA on Tuesday. This team was led by former New Zealand Prime Minister Helen Clark and former Liberian President Ellen Sirleaf. Clark told Tuesday’s technical briefing the panel “has recommended the adoption of a pandemic framework convention within six months, using powers under Article 19 of the WHO constitution”. 

“We see the convention as being complementary to the International Health Regulations,” Clark said. “We think its negotiation should be facilitated by the WHO, with involvement at the highest levels of that negotiation of governments, scientific experts and civil society.”

This convention would fill gaps in the current legal framework, clarify the responsibilities of states and international organisations, reinforce states’ pandemic-related measures and support WHO’s empowerment, she said. 

It also would set up principles and mechanisms for financing preparedness and early response, and for the “global public goods of vaccines, therapeutics, diagnostics, and essential supplies and technology transfer.”

More pointedly, Clark noted that “WHO needs to have unfettered access to the sites of an outbreak, and it shouldn’t need to go through a negotiated process to get there.”

IHR review co-chair Lucille Blumberg said her committee also supports a pandemic treaty to address regulatory gaps that “mostly concern detection, assessment, and alert provisions, as well as preparedness for core capacities. … There are other elements required for a comprehensive global architecture for emergency preparedness and response which seem to fall outside of the IHR. 

“This has made us consider there may be benefits in agreeing on a global legal mechanism that would outline such provisions while supporting and complementing IHR implementation — and this could be done through a pandemic treaty,” Blumberg said.

Image Credits: Twitter: @WHOAFRO, WHO.

Front line healthcare workers at Thailand Bamrasnaradura Infectious Disease Institute faced workforce shortages and had limited access to personal protective equipment as violence against healthcare workers worsened globally.

An unprecedented number of healthcare workers were seriously assaulted last year, even as health workers risked their lives on the front lines of the COVID-19 response. 

Over 412 COVID-related attacks on health workers, including kidnappings and murders, occurred between January and December 2020, experts reported at a World Health Assembly side event. The session Monday was co-organized by the Global Health Center; the Safeguarding Health in Conflict Coalition; the Swiss Confederation; and the Government of Spain. 

Panelists said that as most countries went into lockdown last year, public frustration, anger and anxiety fuelled violence against health workers worldwide. 

Violence against health care in the context of the COVID-19 pandemic in 2020. Reported COVID-19-related violence (in green) peaked in the early weeks of the pandemic and has since fallen.

The majority of perpetrators of pandemic-triggered violence were patients and their family members, or local community members. In 59% of cases, violence was triggered by opposition to COVID diagnostic testing or a decision to hospitalize a patient, said a “Threats and Violence against Health Care during the COVID-19 Pandemic” report by Insecurity Insight.

Healthcare workers faced abuse while traveling to and from work in 30% of cases. In 11% of incidents, health workers were threatened or injured for speaking out against challenges they experienced at work, including protests over the lack of personal protective equipment and masks. 

“Sadly, these violations in dozens of countries and situations of conflict are the new normal. And this normal is not acceptable,” said Susannah Sirkin, Director of Policy and Senior Advisor at Physicians for Human Rights. 

Susannah Sirkin, Director of Policy and Senior Advisor at Physicians for Human Rights.

“It is especially unconscionable during the time of a global health crisis, the COVID-19 pandemic, which compounds the situation of devastation from attacks on health in war and other situations of conflict,” Sirkin added

While generally there were fewer assaults in 2020 compared to previous years, the nature of the events became more severe, with an increase in the number of health workers killed and kidnapped. 

Assaults on Health in Conflict Situations

Beyond COVID-related attacks, deeply-entrenched patterns of violence against health workers in conflict-ridden countries also continued. 

This included attacks on health workers and destruction of health facilities associated with the ongoing conflicts in Libya and Yemen – which continued despite the UN Secretary’s call for a ceasefire due to the pandemic. 

The Central African Republic, plagued by armed conflict, social unrest and political instability, also has seen a high proportion of health facilities destroyed or rendered non-functional.

“Killings, assault, kidnapping, verbal threats and overt acts of intimidation against healthcare workers are commonplace,” said Minister of Health Pierre Somse. 

Pierre Somse, Minister of Health of the Central African Republic.

He said that in the country, the number of attacks against healthcare workers rose 79% from October 2020 to February 2021.

The Central African Republic has one of the world’s lowest physician-to-patient ratios and among the highest rates of maternal and infant mortality. 

In one district in the Central African Republic with high levels of violence against health personnel, tuberculosis vaccination rates also dropped to 45%, as compared to the national average of 81%. 

“Conflict and violence against healthcare workers is worsening inequality and inequities in access to health services,” said Somse. “Addressing all forms of violence against healthcare workers in conflict settings is an urgency. It is needed today more than ever, as we confront COVID-19.”

Trends in Violence Against Health Workers for 2021 

Over the past five years, a health facility in a conflict zone was destroyed or severely damaged every other day, on average. Every two days a health worker was kidnapped or injured, and every three days a health worker was killed. At least 600 health workers were killed and over 1000 health facilities were damaged. This violence was concentrated in Syria, Nigeria, Afghanistan and the Democratic Republic of Congo. 

“Where does this leave us for this year? I’m afraid the picture doesn’t look good,” said Christina Wille, Director of Insecurity Insight, a Geneva-based NGO. “I’m afraid we’ll probably be here next year again with a report that has a few little positive notes to report.”

In 2021, increasing attacks on healthcare workers were witnessed and reported in Tigray, Gaza, and in Myanmar. In Myanmar, there were over 500 arrest warrants issued against healthcare workers since the coup in February.

Barely a day has gone by without violence against health workers being reported in Myanmar. Some 19 health facilities were damaged in Gaza over the past two weeks, including its main COVID-19 laboratory. 

“It seems that whenever there’s violence, it’s accompanied by violence against healthcare,” said Leonard Rubenstein, Chair of the Safeguarding Health in Conflict Coalition. 

Leonard Rubenstein, Chair of the Safeguarding Health in Conflict Coalition.

The violence is sometimes the collateral damage associated with larger strategic objectives. Other times it is an end in itself, as in Afghanistan, where the Taliban forces closures of health facilities in order to exert their leverage over health services. Health workers are sometimes punished for providing care to enemy combatants, although occasionally the violence is a result of recklessness, said Rubenstein.

Actions Needed by States, the UN and WHO

This month marks five years since the United Nations Security Council adopted a resolution against attacks on health workers in situations of armed conflict. On this anniversary, little progress has been made on implementing the resolution and reducing violence. 

“A few states have demonstrated their commitments and followed through on them, but these unfortunately are exceptions,” said Rubenstein.

The resolution was prompted by the 2015 US bombing of the Kunduz Trauma Center in Afghanistan, operated by Médecins sans Frontières, which killed 42 patients and health-care workers. 

An operating room in the Kunduz Trauma Center in Afghanistan, operated by Médecins Sans Frontières, that was destroyed in a US airstrike in 2015.

“In the darkness of the night, my hospital was on fire and I was hearing the screams of patients, caretakers, and staff for help. No one could help them. And all of them, the ones who had been trapped inside, died,” said Masood Nasim, Deputy Medical Coordinator of Médecins sans Frontières in Afghanistan.

“I have seen terrible consequences of attacks on healthcare: patients and medical personnel directly killed and injured, and essential in life saving medical services lost for current and future patients,” said Nasim.

Masood Nasim, Deputy Medical Coordinator of Médecins sans Frontières in Afghanistan.

Calling for Five Concrete Steps by Global Community

“After five years of inaction, the international community must take a much more vigorous stance,” said Rubenstein.  He laid out five concrete steps to be taken by the international community:

  • A special representative of the UN Secretary General should be appointed to monitor and report on the compliance of states with the resolution;
  • Political leaders must demand that ministers of defense get involved in reforming operational procedures and protecting healthcare;
  • WHO should convene health ministers to address the issue of violence against health workers at the ongoing 74th World Health Assembly;
  • WHO must take action to address the underreporting of data collected on violence against healthcare;
  • States and the UN must stop taking actions that undermine protection and legitimize violence against healthcare.

Multiple times over the past five years, the Security Council has blocked referrals to the International Criminal Court. In response, the General Assembly should establish new tribunals to prosecute perpetrators. 

Additionally, member states that sell arms to perpetrators of violence against healthcare must start adhering to laws prohibiting such sales. 

“These five steps take commitment and political will,” said Rubenstein. “We don’t want to meet in another five years and have the same discussion.”

“We all have a role to play in preventing these terrible events, which continuously reduce and impair the capacity of the impact of healthcare systems around the world,” said Maciej Polkowski, Head of the Health Care in Danger Initiative at the International Committee of the Red Cross. 

“The very least we can ask is that people stop attacking medical facilities and healthcare workers who are trying to save human lives,” said Nasim. “It must stop.”

Image Credits: Global Health Center, UN Women Asia and the Pacific.

Receiving a shot of insulin to help control diabetes.

A draft resolution on expanding prevention and treatment for diabetes now appears set for approval at this week’s World Health Assembly – after a number of European countries, as well as the US, removed their opposition to language mandating the World Health Organization to develop targets for expanded diabetes treatment – as well as measures encouraging greater price transparency in the insulin market. 

The resolution awaiting formal approval asks the WHO Director General to assess “the feasibility and potential value of establishing a web-based tool to share information relevant to the transparency of markets for diabetes medicines, including insulin, oral hypoglycaemic agents and related health products, including information on investments, incentives, and subsidies.”

The resolution also asks the Director General to make: “recommendations for the prevention and management of obesity over the life course, including considering the potential development of targets in this regard, and to submit these recommendations to the Seventy-fifth World Health Assembly for its consideration in 2022.”

The draft resolution’s overall goals include promoting “access to diagnostics and quality, safe, effective, affordable and essential medicines, including insulin, oral hypoglycaemic agents and other diabetes-related medicines and health technologies for all people living with diabetes, in accordance with national context and priorities.” 

The resolution’s language also recognises “the importance of international cooperation in support of national, regional, and global plans … including to increase access to treatment such as insulin.” 

Norway Pushed for Even Stronger Language – But Supported ‘Compromise’

Checking blood sugar levels in Kenya for control of diabetes

Obtaining WHA approval for a strong resolution on diabetes – a condition that goes massively undetected and untreated around the world – has been a focus of activity among civil society groups, low- and middle-income countries – as well as some high-income countries such as Norway.

Sources said that Norway had pushed for even stronger language on a price-reporting mechanism, but that what was achieved was a “good compromise.”

Speaking at the WHA’s opening session on Monday, Tonje Borch, senior advisor in Norway’s Minister of Health, expressed strong support for the resolution, suggesting that Norway would like to go even further: “we also strongly support a global price reporting mechanism for insulin – there is clearly a need for more transparency and lower prices will save lives.

“Prices of many new medicines are high, and secret. Lack of transparency is undermining public trust in our health systems. In the case of the Covid-19 vaccines, we have seen that increased transparency is possible and positive. The pandemic encourages us to reflect on the business models and collaborations that have emerged during the pandemic. To achieve the goal of increased transparency, we need to collaborate, both with national health authorities, international organizations and industry. We have a momentum. Now is the time,” Borch said.

In follow-up remarks to Health Policy Watch, Norway’s Minister of International Development, Dag-Inge Ulstein said: “This resolution is important for Norway, since we know that large-scale global efforts to combat diabetes as well as the other NCDs could save millions of lives, contribute to healthier populations and economic growth. This is crucial for achieving the sustainable development goals. This is in line with Norway’s strategy for combating NCDs as a part of our development policy, which was launched in 2019.”

“The high price of insulin today is one of the main reasons for the high death toll of diabetes. We strongly support a global price reporting mechanism for insulin – there clearly is a need for more transparency,” Ulstein added. 

“Such a mechanism would hopefully contribute to bringing the prices down. We are aware that the retail price may be as high as ten times the production costs (“net prices”). In Norway, people with diabetes can live well with their disease, since they have access to affordable insulin. This may not be the case for a poor family in Malawi, having a child with diabetes Type 1 and not being able to provide life-saving insulin. Or having to choose between life-saving insulin for one child or food for the other.”

Civil Society Made Strong Push For Resolution’s Approval 

Dr Helen Bygrave, Médecins Sans Frontières’ (MSF) Access Campaign’s chronic diseases advisor, said she was delighted to see countries like Canada, Brazil and Chile join 19 others in supporting the resolution, which is being led by the Russian Federation. 

“Importantly, the resolution calls for establishing a database to improve the transparency around the price of diabetes medicines, including insulin,” said Bygrave. 

“Insulin is one of the most expensive products in diabetes care, and there is an urgent need to expand access to affordable insulin through price transparency, as well as supporting the harmonisation of regulatory requirements for quality-assured insulins, including biosimilars,” she said.

Currently 420 million people are living with diabetes worldwide. This number is estimated to rise to 578 million by the end of this decade.

An estimated nine million people with type 1 diabetes require insulin to survive and around 60 million people with type 2 diabetes require insulin to manage their condition. Globally, about half of those needing insulin have irregular or no access to it. 

Developed and developing countries differ greatly in diabetes resources available to their populations. As four out of five adults with diabetes live in low-and middle-income countries, these inequalities have huge public health impacts. 

In sub-Saharan Africa, the life expectancy of a child with type 1 diabetes can be as low as one year due to the lack of access to the drug.

Even in developed countries like the United States, high insulin costs mean that many who need the drug don’t get it. 

Three companies — Novo Nordisk, Sanofi, and Eli Lilly — control more than 90% of the global insulin market – a monopoly that leads to unaffordable prices for diabetics in many countries – including even some in high-income countries. The remaining share of the global insulin market is split among approximately seven other insulin manufacturers.

MSF has said that insulin often is not available in public health facilities or private pharmacies in many of the 70 countries worldwide, in which the organisation is active.

To make matters worse, in April 2020, at the peak of the first wave of the COVID-19 pandemic, several countries in Europe also banned the export of insulin fearing that lockdowns would lead to increased insulin demand and shortages, and also possibly disrupting supply chains in other areas. 

People living with diabetes also have a higher risk of becoming severely ill or dying from COVID-19, and are thus among those most impacted by the COVID-19 pandemic. 

Need for targets

Nina Renshaw, policy and advocacy director of the NCD Alliance, also hailed the resolution as evidence of significant progress. 

“It has been through lengthy negotiations for quite a while,” she said. While she said the resolution’s mandate for WHO to develop targets on combating diabetes, don’t specifically mandate the development of a target on access to insulin, she hopes this will change: 

“It is a step along the way in the conversation. We would hope there are ambitious targets around insulin developed in time.”

MSF’s Bygrave also criticized the lack of targets for insulin access as such, saying her organisation would like to see more explicit targets related to global diabetes goals.

“We should be moving towards the more actionable 90-90-90 approach for diagnosis, treatment and control, as outlined in WHO’s Global Diabetes Compact,” she said.  The Compact, launched by WHO and the Government of Canada at a Global Diabetes Summit in April 2021, set broad global goals for addressing the diabetes problem worldwide – but it lacked the official stamp that a WHA resolution endorsed by all 194 member states would provide.  Launch of the Compact coincided with the 100th anniversary of the discovery of insulin.   

 

 

 

 

 

Image Credits: WHO.